Found: 4
Select item for more details and to access through your institution.
Clinical relevance of sST2 in cardiac diseases.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 1, p. 29, doi. 10.1515/cclm-2015-0074
- By:
- Publication type:
- Article
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70454-8
- By:
- Publication type:
- Article
Modulation of IL-33/ ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 7, p. 643, doi. 10.1111/eci.12282
- By:
- Publication type:
- Article